Home/ Supplements/ L Arginine/ N.O.max ER

N.O.max ER

product on market Tablet or Pill XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for N.O.max ER
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 500.0mg (143 products)
ActiNOS
150 mg

Other Ingredients

Hydroxypropyl Methylcellulose Stearic Acid Hydroxypropyl Cellulose Silica Hydroxypropyl Methylcellulose Medium Chain Triglyceride Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take three tablets twice per day: 3 tablets 30 minutes before breakfast and 3 tablets again 30 minutes before lunch with 8 ounces of water.

Warnings & Precautions

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

Keep out of reach of children. This product is not intended for use by individuals under 18 years of age. Storage: Keep closed in a cool, dry place out of reach of children.

Do not use if tamper seal is damaged.

Contains: Milk

Formulation Notes

N.O. max ER represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the "foundation" of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endothelium-the inside of blood vessels. With age comes diminished NO levels; that's why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGEN's extended-release technology, that activity has been realized with N.O. max ER.

Formulated to Exclude: Wheat, gluten, yeast, soy, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, and artificial sweeteners.

Extended-Release Arginine Alpha-Ketoglutarate Clinically-Tested Ingredient

Additional Information

Storage: Keep closed in a cool, dry place out of reach of children.

ePV (ePedigree Verification) Third-Party Verified GMP Compliant

Scan to Learn More! This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00164 3
DSLD Entry Date2025-09-25
Product TypeOther Combinations
FormTablet or Pill
BrandXYMOGEN
DSLD ID335504
Data Updated2026-04-11
Research

Research Evidence

45
Research Sources
52
Avg Quality
12
Rct
11
Systematic Review
11
Meta Analysis
11
Clinical Trial
A Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Nutritional interventions for treating foot ulcers in people with diabetes
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Systematic Review The Cochrane database of systematic reviews 2007 PubMed
B The Effect of Amino Acids on Wound Healing: A Systematic Review and Meta-Analysis on Arginine and Glutamine
Meta Analysis Nutrients 2021 PubMed DOI
B Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use
Meta Analysis Nutrients 2023 PubMed DOI
B Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
B An Analysis of Popular Online Erectile Dysfunction Supplements
Systematic Review The journal of sexual medicine 2019 PubMed DOI
View all evidence for L Arginine →
Compare

Similar Products

View all L Arginine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.